Other languages Femasys Inc.

Equities

FEMY

US31447E1055

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
1.29 ^USD	+4.45%		+1.57%	+32.31%

01/04	HC Wainwright Adjusts Femasys' Price Target to $12 From $10, Reiterates Buy Rating	MT
28/03	Femasys Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Femasys Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Femasys Inc. Announces Positive Topline Data from Pivotal Trial for Its Fda-Cleared Femaseed®? for the Treatment of Infertility	20/03
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution	06/03
Femasys Inc. Appoints Richard Spector as Chief Commercial Officer	06/02
Femasys Begins Patient Enrollment for Permanent Birth Control Candidate Trial	26/01
Femasys Inc. Begins Fembloc Pivotal Trial Enrollment At UC Davis Medical Center, A Hub for Innovation and Groundbreaking Research in Health Care for Women	26/01
Femasys Inc. Begins Fembloc Pivotal Trial Enrollment At University of Utah	23/01
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine	15/12
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer	30/11
Femasys Inc. Completes Enrollment of Femaseed Pivotal Trial in Support of Commercial Launch	30/11
Femasys Inc. Appoints Joshua Silverman as Director	22/11
Femasys Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Femasys Inc. Successfully Completes the Stage 2 European Union (EU) Medical Device Regulation	26/23/26
Top Premarket Decliners	04/23/04
Top Midday Gainers	29/23/29
Top Midday Decliners	28/23/28
Femasys Activates Enrollment in Trial of FemBloc Birth Control Candidate	27/23/27
Femasys Inc. Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site to Participate	27/23/27
Top Premarket Decliners	27/23/27
Sector Update: Health Care Stocks Lower Late Tuesday Afternoon	27/23/27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Femasys Inc.

Equities

FEMY

US31447E1055

Other languages

Filters